FDPS and neoplasm: While the optimum dose and timing of zoledronate administration remain to be elucidated, the local administration of zoledronate is desired to inhibit FPP synthase and sensitize tumor cells in the abdominal cavity to efficient Vγ9Vδ2 T-cells recognition.